Life Scientist > Biotechnology

QrxPharma lists on OTCQX

01 July, 2008 by Dylan Bushell-Embling

To trade in 'pink-sheets', or over-the-counter securities, on the international trading exchange


Resonance tests FerriScan

01 July, 2008 by Dylan Bushell-Embling

Resonance Health applies for reimbursement for FerriScan


VISTECH grant for Anadis

01 July, 2008 by Dylan Bushell-Embling

Anadis wins grant for alimentary mucositis treatment trials


Saint Bob accompanies Eastland

01 July, 2008 by Dylan Bushell-Embling

Eastland demonstrates ArTiMist to Sierra Leone officials


LCT waiting for minister

26 June, 2008 by Kate McDonald

Living Cell Technologies awaits decision by NZ health minister on local trial


LCT reports long-term insulin uptake

25 June, 2008 by Dylan Bushell-Embling

Living Cell Technologies demonstrates porcine insulin uptake after 11 months


Alchemia wins patents for generic fondaparinux

25 June, 2008 by Dylan Bushell-Embling

Patent family grows for synthetic heparin oligosaccharides


Acrux gets go-ahead for Phase III

25 June, 2008 by Dylan Bushell-Embling

Approval to commence Phase III trials of testosterone treatment


Viralytics on track with IV delivery

25 June, 2008 by Dylan Bushell-Embling

Single intravenous dose of Cavatrak passes safety trial


AOS to face competition

25 June, 2008 by Dylan Bushell-Embling

Competing product cleared for sale by FDA


Portland's strategy on track

25 June, 2008 by Dylan Bushell-Embling

Portland increases sales and revenue, offers rights issue to raise cash


Apollo's proteins sold to NZ

24 June, 2008 by Kate McDonald

NZ biotech Symansis has bought Apollo Cytokine Research.


Novotech wins CRO of the year

20 June, 2008 by Kate McDonald

Sydney's Novotech has won another Frost & Sullivan award


Big deal for Bionomics

20 June, 2008 by Dylan Bushell-Embling

Bionomics to license compounds to Merck Serono for MS treatment development


SpermSep in top 20

20 June, 2008 by Dylan Bushell-Embling

NuSep's fertility device among top 20 projects to be funded by ARC


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd